½ÃÀ庸°í¼­
»óǰÄÚµå
1362889

¼¼°èÀÇ Àν¶¸° ÆÐÄ¡ ÆßÇÁ ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× µ¿Ç⠺м® º¸°í¼­ : Àü´Þ ¸ðµåº°, Á¦Ç° À¯Çüº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2023-2030³â)

Insulin Patch Pumps Market Size, Share & Trends Analysis Report By Delivery Mode (Basal, Bolus, Basal & Bolus), By Product Type (Disposable, Reusable), By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Grand View Research | ÆäÀÌÁö Á¤º¸: ¿µ¹® 110 Pages | ¹è¼Û¾È³» : 2-10ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Àν¶¸° ÆÐÄ¡ ÆßÇÁ ½ÃÀåÀÇ ¼ºÀå°ú µ¿Çâ :

Grand View Research, Inc.ÀÇ ÃֽŠº¸°í¼­¿¡ µû¸£¸é ¼¼°è Àν¶¸° ÆÐÄ¡ ÆßÇÁ ½ÃÀå ±Ô¸ð´Â 2030³â±îÁö 20¾ï 6,210¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ¿¹Ãø ±â°£ µ¿¾È 10.9%ÀÇ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ÀÌ ½ÃÀåÀº ÁÖ·Î ´ç´¢º´ Àα¸ Áõ°¡¿Í °í±Þ ´ç´¢º´ °ü¸® ¼Ö·ç¼Ç¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¼ºÀå¼¼¸¦ º¸À̰í ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àν¶¸° ÆÐÄ¡ ÆßÇÁ ºÐ¾ßÀÇ ±â¼ú ¹ßÀü°ú ´Ù¾çÇÑ Á¦Ç° Ãâ½Ã·Î ÀÎÇØ ¼ºÀå¼¼°¡ ´õ¿í °¡¼ÓÈ­µÇ°í ÀÖ½À´Ï´Ù.

ÆÐÄ¡ ÆßÇÁ´Â »ç¿ëÇϱ⠽±°í ±âÁ¸ Àν¶¸° ÆßÇÁº¸´Ù Æí¸®ÇÕ´Ï´Ù. ÀϹÝÀûÀ¸·Î ÀÌ·¯ÇÑ ÆßÇÁ´Â Áö¼ÓÀû ¶Ç´Â Ç÷´ç ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ ¿¬°áµË´Ï´Ù. ¶ÇÇÑ ÆÐÄ¡ ÆßÇÁ´Â ±âÁ¸ Àν¶¸° ÆßÇÁº¸´Ù °¡°ÝÀÌ Àú·ÅÇÏ¿© Àν¶¸° Àü´Þ ½ÃÀå¿¡¼­ ºü¸£°Ô Å« Á¡À¯À²À» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. ÁÖ¿ä ½ÃÀå ±â¾÷µéÀº »õ·Î¿î ±â¼úÀ» »ç¿ëÇÏ¿© »ç¿ëÀÚ Ä£È­ÀûÀÎ Àν¶¸° Àü´Þ ¼Ö·ç¼ÇÀ» Àú·ÅÇÑ °¡°ÝÀ¸·Î Á¦°øÇÕ´Ï´Ù. ÀÌ·Î ÀÎÇØ ¿¹Ãø ±â°£ µ¿¾È Á¦Ç° Ãâ½Ã ºóµµ°¡ Áõ°¡ÇÏ¿© Àüü »ê¾÷ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

´ç´¢º´ °ü·Ã ÀÇ·áºñ ÁöÃâ Áõ°¡¿Í FDA ½ÂÀÎ °Ç¼ö Áõ°¡·Î ÀÎÇØ ¾÷°è ¼ºÀå¿¡ ´õ¿í ¹ÚÂ÷¸¦ °¡Çϰí ÀÖ½À´Ï´Ù. ±¹Á¦´ç´¢º´¿¬¸Í¿¡ µû¸£¸é ¼¼°è ´ç´¢º´ °ü·Ã ÀÇ·áºñ ÁöÃâÀº ¾à 9,660¾ï ´Þ·¯·Î 2045³â±îÁö 1Á¶ 537¾ï ´Þ·¯·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 2019³â 3¿ù Çѱ¹ÀÇ EoFlow´Â ¹Ì±¹¿¡¼­ »õ·Î¿î µðÀÚÀÎÀÇ ÆÐÄ¡ ÆßÇÁ EoPatch¿¡ ´ëÇÑ FDA ½ÂÀÎÀ» ȹµæÇß½À´Ï´Ù. ¶ÇÇÑ, ³ëÀÎ Àα¸ Áõ°¡´Â ¿¹Ãø ±â°£ µ¿¾È ½ÃÀå ¼ºÀå¿¡ µµ¿òÀÌ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Àα¸¹®Á¦¿¬±¸¼ÒÀÇ '¹Ì±¹ÀÇ °í·ÉÈ­' º¸°í¼­¿¡ µû¸£¸é, ¹Ì±¹ÀÇ 65¼¼ ÀÌ»ó ³ëÀÎ Àα¸´Â 2016³â ¾à 4,600¸¸ ¸í¿¡¼­ 2060³â 9,800¸¸ ¸í ÀÌ»óÀ¸·Î Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

Àν¶¸° ÆÐÄ¡ ÆßÇÁ ½ÃÀå º¸°í¼­ ÇÏÀ̶óÀÌÆ®

  • Àü´Þ ¸ðµåº°·Î´Â 1Çü ´ç´¢º´ ȯÀÚ¿Í 2Çü ´ç´¢º´ ȯÀÚ ¸ðµÎ ±âÃÊ ¿ä¹ý°ú º¼·ç½º ¿ä¹ýÀÌ ³Î¸® »ç¿ëµÇ±â ¶§¹®¿¡ 2022³â¿¡´Â ±âÃÊ ¿ä¹ý°ú º¼·ç½º ¿ä¹ý ºÎ¹®ÀÌ ½ÃÀåÀ» Àå¾ÇÇß½À´Ï´Ù.
  • Á¦Ç° À¯Çüº°·Î´Â Àç»ç¿ë °¡´ÉÇÑ ºÎ¹®ÀÌ 2022³â °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, ÀÌ·¯ÇÑ ÀåÄ¡ÀÇ Ã¤ÅÃÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °¡Àå ºü¸¥ ¼Óµµ·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ÆÇ¸Å ä³Îº°·Î´Â º´¿ø ºÎ¹®ÀÌ Á¾ÇÕÀûÀÎ ¹è¼Û ³×Æ®¿öÅ© È®´ë·Î ÀÎÇØ 2022³â °¡Àå Å« ¸ÅÃâ ºñÁßÀ» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
  • ºÏ¹Ì´Â À¯¸®ÇÑ »óȯ Á¤Ã¥°ú ÀϺΠÇõ½ÅÀûÀÎ ÆÐÄ¡ ÆßÇÁÀÇ Ãâ½Ã·Î ÀÎÇØ 2022 ³â¿¡ °¡Àå Å« ¸ÅÃâ Á¡À¯À²À» Â÷ÁöÇß½À´Ï´Ù.
  • ¾Æ½Ã¾ÆÅÂÆò¾çÀº ´ç´¢º´ Àα¸ Áõ°¡¿Í ´ç´¢º´ ¿¹¹æ ÀÇ·á¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹Ãø ±â°£ µ¿¾È °ßÁ¶ÇÑ ¼ºÀåÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý°ú ¹üÀ§

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ ½ÃÀå º¯¼ö, µ¿Çâ, ¹üÀ§

  • ½ÃÀå °èÅë Àü¸Á
    • »óÀ§ ½ÃÀå Àü¸Á
    • °ü·Ã/ºÎ¼ö ½ÃÀå Àü¸Á
  • º¸±Þ°ú ¼ºÀå Àü¸Á ¸ÅÇÎ
  • ½ÃÀå ¿ªÇÐ
    • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ ºÐ¼®
    • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ ºÐ¼®
  • ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ ½ÃÀå ºÐ¼® Åø
    • ¾÷°è ºÐ¼® - PorterÀÇ Five Forces ºÐ¼®
    • PESTEL ºÐ¼®

Á¦4Àå ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ : ¼Û´Þ ¸ðµå ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ ½ÃÀå : Áß¿ä Æ÷ÀÎÆ®
  • ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ ½ÃÀå : µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • Basal
  • Bolus
  • Basal & Bolus

Á¦5Àå ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ : Á¦Ç° À¯Çü ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ ½ÃÀå : Áß¿ä Æ÷ÀÎÆ®
  • ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ ½ÃÀå : µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • ÀÏȸ¿ë
  • ÀçÀÌ¿ë °¡´É

Á¦6Àå ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ : À¯Åë ä³Î ÃßÁ¤¡¤µ¿Ç⠺м®

  • ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ ½ÃÀå : Áß¿ä Æ÷ÀÎÆ®
  • ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ ½ÃÀå : µ¿Çâ°ú ½ÃÀå Á¡À¯À² ºÐ¼®, 2022³â ¹× 2030³â
  • º´¿ø
  • ¼Ò¸Å ¾à±¹
  • ÇÁ¶óÀ̺ø Ŭ¸®´Ð
  • ¿Â¶óÀÎ ¾à±¹
  • ±âŸ

Á¦7Àå ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ ½ÃÀå : Áö¿ª ÃßÁ¤¡¤µ¿Ç⠺м®

  • Áö¿ªº° Àü¸Á
  • Áö¿ªº° ÆÐÄ¡½Ä Àν¶¸° ÆßÇÁ ½ÃÀå : ÁÖ¿ä ¸¶ÄÏ Ç÷¹À̽º Æ÷ÀÎÆ®
  • ºÏ¹Ì
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦8Àå °æÀï ±¸µµ

  • ÁÖ¿ä ½ÃÀå ÁøÃâ±â¾÷¿¡ ÀÇÇÑ ÃÖ±Ù µ¿Çâ°ú ¿µÇ⠺м®
  • ½ÃÀå ÁøÃâ±â¾÷ ºÐ·ù
    • Medtronic Plc
    • F. Hoffmann - La Roche Ltd.
    • Insulet Corporation
    • CeQur
    • Terumo
    • Tandem diabetes care
    • Medtrum
    • Debiotech
LSH 23.10.27

Insulin Patch Pumps Market Growth & Trends:

The global insulin patch pumps market size is expected to reach USD 2,062.1 million by 2030, registering a CAGR of 10.9% during the forecast period, according to a new report by Grand View Research, Inc.. The market is primarily driven by factors such as increasing diabetic population and rising awareness regarding advanced diabetes management solutions. Moreover, technological advancements and several product launches in the field of insulin patch pumps are further augmenting the growth.

Patch pumps are easy to use and more convenient than conventional insulin pumps. Usually, these pumps are connected to a continuous or blood glucose monitoring system. In addition, patch pumps are more affordable than conventional insulin pumps and are rapidly capturing a significant share in the insulin delivery market. Key market players are using novel technologies and offering user-friendly insulin delivery solutions at lower prices. This is expected to increase the frequency of product launches during the forecast period, thus boosting the overall industry growth.

Increasing healthcare expenditure related to diabetes and the rising number of FDA approvals are further aiding the industry growth. According to the International Diabetes Federation, the global total diabetes-related health expenditure was about USD 966,000 Million, which is expected to increase to USD 1,053,700 Million by 2045. In March 2019, EoFlow, a South Korean Company, received FDA approval for its newly designed patch pump, EoPatch in the U.S. Moreover, the growing geriatric population is expected to aid the market growth over the forecast period. According to the "Aging in the United States" report by the Population Reference Bureau, there will be more than 98 million people in the U.S. who are 65 years of age or older by 2060, up from about 46 million in 2016.

Insulin Patch Pumps Market Report Highlights:

  • By delivery mode, the basal and bolus segment dominated the market in 2022 owing to the wide usage of the basal and bolus therapy in both type1 and type 2 diabetes patients
  • By product type, the reusable segment held the largest revenue share in 2022 and is expected to grow at the fastest rate during the forecast period due to increasing adoption of these devices
  • By distribution channel, the hospitals segment held the largest revenue share in 2022 due to the expansion of the integrated delivery network
  • North America accounted for the largest revenue share in 2022 owing to favorable reimbursement policies and launch of several innovative patch pumps
  • Asia Pacific is expected to witness robust growth during the forecast period owing to the increasing diabetic population, coupled with rising awareness regarding diabetes preventive care

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Delivery Mode
    • 1.1.2. Product Type
    • 1.1.3. Distribution Channel
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Delivery mode outlook
    • 2.2.2. Product type outlook
    • 2.2.3. Distribution Channel outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Insulin Patch Pumps Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Insulin Patch Pumps Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Insulin Patch Pumps: Delivery Mode Estimates & Trend Analysis

  • 4.1. Insulin Patch Pumps Market: Key Takeaways
  • 4.2. Insulin Patch Pumps Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Basal
    • 4.3.1. Basal market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Bolus
    • 4.4.1. Bolus market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Basal and Bolus
    • 4.5.1. Basal and Bolus market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Insulin Patch Pumps: Product Type Estimates & Trend Analysis

  • 5.1. Insulin Patch Pumps Market: Key Takeaways
  • 5.2. Insulin Patch Pumps Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Disposable
    • 5.3.1. Disposable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Reusable
    • 5.4.1. Reusable market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Insulin Patch Pumps: Distribution Channel Estimates & Trend Analysis

  • 6.1. Insulin Patch Pumps Market: Key Takeaways
  • 6.2. Insulin Patch Pumps Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospitals
    • 6.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Retail pharmacies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Private Clinics
    • 6.5.1. Private clinics market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Online Pharmacies
    • 6.6.1. Online pharmacies market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.7. Others
    • 6.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Insulin Patch Pumps Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Insulin Patch Pumps Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Medtronic Plc
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. F. Hoffmann - La Roche Ltd.
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Insulet Corporation
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. CeQur
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Terumo
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Tandem diabetes care
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Medtrum
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Debiotech
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦